期刊文献+

低剂量多巴酚丁胺负荷磁共振成像在缺血性心脏病中的应用研究 被引量:1

Low-dose Dobutamine Stress MRI Myocardial Perfusion and Assessment of Myocardial Viability
下载PDF
导出
摘要 准确有效地评价心肌活性对于缺血性心脏病具有实际的临床意义。随着心脏磁共振成像技术的快速发展,磁共振成像在检测心肌活性方面表现出诸多优势,提供了多种心肌活性的评估技术,其中低剂量多巴酚丁胺负荷磁共振成像对活性心肌的判断具有高度的特异性,并能了解心肌收缩储备。现就低剂量多巴酚丁胺负荷磁共振成像在缺血性心脏病应用及研究进展做一综述。 Accurately and effectively evaluating myocardial viability for ischemic heart disease has practical clinical significance.With the rapid development of cardiac magnetic resonance imaging technology,the detection of myocardial viability provides many advantages and ways to assess myocardial viability and low-dose dobutamine stresses. Magnetic resonance imaging is quickly becoming a prominent effective inspection method. The purpose of this article is to review the assessment of myocardial viability by low-dose dobutamine stress magnetic resonance imaging and its advancements in treating ischemic heart disease.
出处 《心血管病学进展》 CAS 2016年第3期285-288,共4页 Advances in Cardiovascular Diseases
基金 国家自然科学基金(81260213) 云南省科技厅-昆明医科大学联合专项基金(2012FB054) 云南省教育厅科学研究重点项目(2014Z057) 云南省中青年学术和技术带头人培养项目(2015HB068)
关键词 缺血性心脏病 心肌活性 低剂量多巴酚丁胺 磁共振成像 Ischemic heart disease Myocardial viability Low-dose dobutamine Magnetic resonance imaging
  • 相关文献

参考文献22

  • 1Marra MP, Lima JAC, Iliceto S. MRI in acute myocardial infttrction[ J]. Eur Heart J, 2011,32 ( 3 ) :284-293.
  • 2Jaarsma C, Leiner T, Bekkers SC, et al. Diagnostic perforraance of noninvasive myocardial perfusion imaging using single-photon emission computed tomo- graphy, cardiac magnetic resonance, and positron emission tomography imaging for the detection of obstructive coronary artery disease : a meta-analysis [ J ]. J Am Coll Cardiol,2013,59 (19) : 1719-1728.
  • 3Heydari B, Jerosch M. Assessment of myocardial ischemia with cardiovascular magnetic resonance[ J~. Prog Cardiovasc Dis,2011,54(3) :191-203.
  • 4Grover S, Sfinivasan G, Selvanayagam JB. Evaluation of myocardial viability with cardiac magnetic resonance imaging [ J ]. Prog Cardiovasc Dis, 2011, 54 (3) :204-214.
  • 5Thouet T, Sehnackenburg B, Kokocinski T, et al. Visualization of chronic myo- cardial infarction using the intravascular contrast agent MS-325 (gadofosveset) in patients[ J]. Sci World J,2012,2012( 1 ) :236401.
  • 6Schuster A, Paul M, Bettencourt N, et al. Myocardial feature tracking reduces observer-dependence in low-dose dobutamine stress cardiovascular magnetic res- onance[J]. PLoS One,2015,10(4) :e0122858.
  • 7Wellnhofer E, Olariu A, Klein C, et al. Magnetic resonance low-dose dobu- tamine test is superior to SCAR quantification for the prediction of functional re- covery[J]. Circulation,2004,109(18) :2172-2174.
  • 8Weinsaft JW, Klem I, Judd RM. MRI for the assessment of myocardial viability [ J ]. Magn Reson Imaging Clin N Am,2007,15 (1) :505-525.
  • 9Tomlinson DR, Beeher H, Selvanayagam JB. Assessment of myocardial viability : comparison of echocardiography versus cardiac magnetic resonance imaging inthe currentera[ Jl. Heart Lung Circ,2008,17(3) :173-185.
  • 10Ogawa M, Doi k, Fukumoto A, et al. Reverse-remodeling after coronary artery by- pass grafting in ischemic cardiomyopathy : assessment of myocardial viability by delayed-enhanced magnetic resonance imaging can help cardiac surgeons [ J]. Interact Cardiovasc Thorac Surg,2007,6(5 ) :673-675.

二级参考文献5

共引文献4

同被引文献6

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部